These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18574356)

  • 41. [The role of strong opioids in the treatment of the chronic musculoskeletal pain].
    Cwiek R; Gasik R; Lisowska B
    Pol Merkur Lekarski; 2008 Jun; 24(144):552-5. PubMed ID: 18702342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
    Prescrire Int; 2009 Oct; 18(103):205. PubMed ID: 19882786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unavailability of narcotic analgesics for ambulatory cancer patients in New York City.
    Kanner RM; Portenoy RK
    J Pain Symptom Manage; 1986; 1(2):87-9. PubMed ID: 2877034
    [No Abstract]   [Full Text] [Related]  

  • 44. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F; Ossipov MH
    Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Issues in medical malpractice XII.
    Tan SY
    Hawaii Med J; 2007 Jun; 66(6):167. PubMed ID: 17621866
    [No Abstract]   [Full Text] [Related]  

  • 46. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of cancer pain: ESMO clinical recommendations.
    Jost L; Roila F;
    Ann Oncol; 2008 May; 19 Suppl 2():ii119-21. PubMed ID: 18456748
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cancer pain management using opioid together with NSAIDs at Sakai Kinki University Hospital].
    Iwasaki H; Hirose Y; Morita T; Matsuoka H; Otsuka M
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1391-3. PubMed ID: 19692787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M; White N; Jean CS; Zempsky WT; Steven K
    J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid-induced pain.
    Prommer EE
    J Clin Oncol; 2008 Jul; 26(20):3464-5; author reply 3465. PubMed ID: 18612166
    [No Abstract]   [Full Text] [Related]  

  • 52. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The physician: a secure base.
    Gerretsen P; Myers J
    J Clin Oncol; 2008 Nov; 26(32):5294-6. PubMed ID: 18854566
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical approaches to special issues related to opioid therapy.
    Fine PG
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S20-8. PubMed ID: 19447318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Access and intensity of use of prescription analgesics among older Manitobans.
    Sadowski CA; Carrie AG; Grymonpre RE; Metge CJ; St John P
    Can J Clin Pharmacol; 2009; 16(2):e322-30. PubMed ID: 19483264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical inquiries: is there a well-tested tool to detect drug-seeking behaviors in chronic pain patients?
    Gianutsos LP; Safranek S; Huber T
    J Fam Pract; 2008 Sep; 57(9):609-10. PubMed ID: 18786335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alleged medical abandonment in chronic opioid analgesic therapy: case report.
    Fishbain DA; Lewis JE; Gao J; Cole B; Rosomoff RS
    Pain Med; 2009; 10(4):722-9. PubMed ID: 19453957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Indication and use of adjuvant analgesics on chronic pain].
    Iseki M
    Masui; 2008 Nov; 57(11):1359-70. PubMed ID: 19039962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioids in non-cancer pain--a critical read of Cicero et al.
    McQuay HJ; Moore RA
    Pain; 2009 Jul; 144(1-2):3-4. PubMed ID: 19443119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.